Congresos

Título Añoorden ascendente
A structure-based thermodynamic analysis of inhibitor binding and drug resistance mutations in HIV-1 protease 1999
Measuring lateral interactions between adsorbed protein molecules by isothermal titration calorimetry 1999
El proyecto del Laboratorio del Amplificador de Energía: desarrollos y objetivos 1999
Thermodynamic characterization of tripeptide inhibitors of the HIV-1 protease 1999
Caracterización genética de la raza porcina Chato Murciano. 1998
A NOVEL THERAPEUTIC APPROACH FOR GLIOMAS: AN ADENOVIRUS DESIGN TO REPLICATE EXCLUSIVELY IN Rb-MUTANT CELLS. 1998
A NOVEL THERAPEUTIC APPROACH FOR GLIOMAS: AN ADENOVIRUS DESIGN TO REPLICATE EXCLUSIVELY IN Rb-MUTANT CELLS. 1998
INFECTION WITH ADENOVIRUS E1B DEFECTIVES EXERTS A MARKED CYTOPATHIC EFFECT ON MICE CELLS DEFICIENT IN P16, P21, P27 OR P53 GENES 1998
SYNERGISTIC EFFECT OF p53, p53-p16 AND E2F-1 IN GLIOMAS SUGGEST DIFFERENT MECHANISM OF ACTIVATION OF APOPTOSIS. 1998
THE ADENOVIRUS E1a GENE IN CANCER GENE THERAPY. 1998
A NEW TOOL FOR GLIOMA TREATMENT: A MUTANT ADENOVIRUS THAT REPLICATES PREDOMINANTLY IN DIVIDING CELLS WITH ALTERED EXPRESSION OF Rb. 1998
TUMOR SUPPRESOR EFFECT OF THE ADENOVIRUS E1A GENE. 1998
E2F-DEPENDENT GLIOMA APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF E2F-TARGET GENES 1998
THE ADENOVIRUS E1A GENE IN CANCER THERAPY 1998
AN ANTITUMOR TREATMENT IN HUMAN CANCER WITH E1B GENE DEFECTIVE ADENOVIRUSES 1998
ENDOR and HYSCORE characterization of flavoprotein semiquinones in relation to protein function 1998
A BICISTRONIC RECOMBINANT ADENOVIRUS CARRYING BOTH P53 AND P16 TUMOR SUPPRESSO GENES FOR TREATMENT OF P53-RESISTANT GLIOMAS. 1998
ANTITUMOR EFFECT OF ADENOVIRUS E1b DEFECTIVES IN UVEAL MELANOMAS. 1998
Kinetic studies of the binding mechanism of FMN to Anabæna apoflavodoxin 1998
Forensic identification of deer and human DNA profiles in a case of furtive hunting. 1998

Páginas